Project Grant K23DK143316
Award Date 4/1/26
Completion Date 3/31/31
Dollars Obligated $197K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- Federal Project Grant Award Summary Massachusetts General Hospital received a $661,694 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 3, 2025. The award, with a completion date of June 30, 2029, funds research to understand the non-canonical role of FANCD2 (Fanconi Anemia Complementation Group D2) as a transcriptional regulator in kidney...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $110,865 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through March 31, 2031. The award funds investigator-initiated research examining c-kit receptor signaling in the modulation of kidney collecting duct function. The research aims to elucidate the...
- Federal Grant Award Summary This $193,809 Project Grant, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), funds clinical research investigating the efficacy and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for treating acute cardiorenal syndrome. The award, effective August 1, 2025, through April 30, 2030, supports research conducted at Yale...
- This Project Grant award of $199,130 was obligated on July 15, 2025, by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). Massachusetts General Hospital will conduct research to demonstrate the clinical utility of Patient-Reported Outcome Measures (PROMs) in advancing patient-centered care for individuals with advanced chronic kidney disease (CKD). The research will develop...
- Federal Grant Award Summary Boston Medical Center Corporation received a $194,147 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026, through November 30, 2030. The award funds the development and testing of a novel first-person storytelling (FPS) narrative video education intervention tailored specifically for Spanish-speaking...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $155,562 to Stony Brook University (operating through The Research Foundation For The State University Of New York) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, dated December 11, 2025, supports research investigating alterations of branched chain amino acid (BCAA) catabolism in acute kidney injury...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $761,577 project grant awarded March 15, 2026, by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports fundamental research investigating the roles of histone modifications—specifically H3K4 methylation (H3K4me) and H3K27 methylation (H3K27me)—in regulating hematopoiesis (blood cell...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $579,097 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, through March 31, 2030. This award funds research investigating the regulation of mitochondrial respiration in diabetic kidney disease (DKD), with the goal of identifying novel...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Columbia University's Health Sciences Division a $231,270 Project Grant effective September 15, 2025, through August 31, 2027, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports large-scale rare variant analyses across major international biobanks—including the UK Biobank, All of Us (AoU), Genomics England, and the Pakistan...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Broad Institute of MIT and Harvard a $882,180 Project Grant on September 19, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct massive-scale genomic risk assessment informing precision medicine across monogenic and common forms of diabetes. The award, with an ultimate completion date of May 31, 2030, supports analysis...